NASDAQ:IPHA
Innate Pharma S.A.
- Stock
Last Close
1.93
02/05 08:31
Market Cap
163.52M
Beta: 0.32
Volume Today
18.96K
Avg: 17.77K
PE Ratio
−1.87
PFCF: −9.30
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.22M - | 745K 38.68% | 3.16M - | 3.16M 0% | 2.80M 11.50% | 2.80M 0% | -1K - | -1K 0% | |||
average payables | 5.99M - | 33.19M 453.82% | 37.57M 13.18% | 17.78M 52.66% | 30.82M 73.31% | 34.81M 12.92% | 28.74M 17.44% | 29.06M 1.11% | 24.74M 14.85% | 18.96M 23.35% | |
average receivables | 7.82M - | 9.27M 18.44% | 17.75M 91.56% | 20.32M 14.47% | 80.86M 297.96% | 79.89M 1.20% | 17.42M 78.20% | 20.06M 15.15% | 28.38M 41.51% | 46.95M 65.42% | |
book value per share | 1.49 - | 1.35 9.30% | 1.60 18.53% | 1.58 1.13% | 2.85 79.92% | 3.25 14.20% | 1.98 39.19% | 1.35 31.64% | 0.68 49.66% | 0.65 5.12% | |
capex per share | -0.05 - | -0.14 196.50% | -0.17 25.88% | -0.11 36.42% | -0.02 78.07% | -0.98 3,920.47% | -0.14 85.38% | -0.02 88.30% | -0.01 15.74% | -0.03 107.68% | |
capex to depreciation | -1.00 - | -2.79 178.73% | -2.88 3.32% | -1.37 52.35% | -0.19 85.92% | -3.96 1,949.25% | -0.20 94.98% | -0.29 45.68% | -0.02 91.46% | -0.46 1,771.17% | |
capex to operating cash flow | 0.13 - | -0.04 127.54% | 0.25 816.44% | 0.13 50.81% | 0.04 64.97% | -1.87 4,363.10% | 0.22 111.63% | 0.02 89.55% | 0.06 157.47% | 0.07 23.43% | |
capex to revenue | -2.58 - | -0.41 84.01% | -0.17 59.51% | -0.18 10.41% | -0.02 90.31% | -0.95 5,201.23% | -0.20 79.06% | -0.11 44.68% | -0.02 79.42% | -0.05 100.66% | |
cash per share | 1.38 - | 4.42 220.00% | 3.67 16.93% | 2.14 41.79% | 2.85 33.42% | 3.27 14.76% | 1.92 41.27% | 1.51 21.58% | 1.27 15.42% | 1.15 9.82% | |
days of inventory on hand | 44.99 - | 45.26 - | |||||||||
days payables outstanding | 206.73 - | 225.80 - | 3.54K 1,469.67% | ||||||||
days sales outstanding | 3.45K - | 202.78 94.13% | 166.08 18.10% | 168.72 1.59% | 669.94 297.06% | 69.54 89.62% | 139.33 100.36% | 555.09 298.40% | 281.96 49.20% | 390.71 38.57% | |
debt to assets | 0.05 - | 0.01 73.54% | 0.02 54.19% | 0.02 21.54% | 0.01 56.42% | 0.05 365.47% | 0.06 33.09% | 0.17 166.44% | 0.20 22.87% | 0.22 6.55% | |
debt to equity | 0.06 - | 0.05 7.58% | 0.06 18.68% | 0.07 10.35% | 0.03 60.37% | 0.09 218.49% | 0.12 42.10% | 0.41 236.57% | 0.78 89.44% | 0.77 1.49% | |
dividend yield | 0.00 - | ||||||||||
earnings yield | -0.05 - | -0.01 81.58% | 0.02 275.85% | -0.18 1,249.50% | 0.01 103.78% | -0.05 853.52% | -0.26 392.43% | -0.17 35.44% | -0.38 126.29% | -0.04 90.51% | |
enterprise value | 336.12M - | 585.13M 74.08% | 616.45M 5.35% | 168.58M 72.65% | 289.21M 71.56% | 214.61M 25.80% | 155.57M 27.51% | 294.30M 89.18% | 220.04M 25.23% | 180.07M 18.16% | |
enterprise value over ebitda | -18.83 - | -72.33 284.06% | 52.94 173.20% | -4.73 108.93% | 23.39 594.65% | -24.16 203.28% | 3.61 114.94% | -7.98 321.08% | 6.52 181.70% | -10.40 259.51% | |
ev to operating cash flow | -18.54 - | 2.81 115.18% | -16.73 694.39% | -3.51 79.03% | -8.89 153.45% | 6.15 169.12% | -3.00 148.87% | -5.03 67.66% | -11.49 128.19% | -5.53 51.86% | |
ev to sales | 370.59 - | 32.68 91.18% | 10.98 66.41% | 5.17 52.93% | 3.62 29.93% | 3.11 14.05% | 2.74 12.03% | 24.30 787.68% | 4.43 81.76% | 3.47 21.73% | |
free cash flow per share | -0.41 - | 3.75 1,019.66% | -0.86 122.86% | -1.00 15.92% | -0.58 41.94% | -0.46 21.16% | -0.80 75.47% | -0.75 5.96% | -0.25 66.13% | -0.43 70.44% | |
free cash flow yield | -0.05 - | 0.27 628.39% | -0.06 121.52% | -0.21 251.22% | -0.08 62.34% | -0.08 1.65% | -0.23 202.07% | -0.17 26.80% | -0.08 54.21% | -0.17 114.03% | |
graham net net | 1.20 - | 0.18 85.25% | 0.40 124.20% | -0.71 277.84% | -0.11 84.46% | 0.71 746.24% | 0.21 70.67% | -0.33 259.19% | -0.29 11.23% | 0.02 107.73% | |
graham number | 3.62 - | 1.95 46.08% | 2.91 48.82% | 5.63 93.67% | 1.82 67.62% | 4.79 162.64% | 6.31 31.89% | 4.75 24.70% | 4.36 8.21% | 1.17 73.22% | |
income quality | 0.92 - | -31.00 3,459.07% | -2.92 90.60% | 0.99 134.07% | -10.67 1,174.16% | -1.68 84.23% | 0.81 148.13% | 1.11 36.71% | 0.33 70.22% | 4.30 1,204.67% | |
intangibles to total assets | 0.06 - | 0.03 46.20% | 0.03 1.32% | 0.18 462.00% | 0.19 3.43% | 0.24 28.96% | 0.15 37.68% | 0.17 9.72% | 0.01 95.47% | 0.00 69.83% | |
interest coverage | -121.01 - | -77.50 35.96% | 61.06 178.79% | -353.83 679.52% | 50.45 114.26% | -132.61 362.85% | -2.02 98.47% | -11.97 491.01% | -2.19 81.70% | -12.21 457.72% | |
interest debt per share | 0.09 - | 0.07 16.35% | 0.10 38.80% | 0.11 8.68% | 0.08 28.46% | 0.28 259.57% | 0.33 15.77% | 0.61 85.22% | 0.60 1.52% | 0.52 13.17% | |
inventory turnover | 8.11 - | 8.06 - | |||||||||
invested capital | 0.06 - | 0.05 7.58% | 0.06 18.68% | 0.07 10.35% | 0.03 60.37% | 0.09 218.49% | 0.12 42.10% | 0.41 236.57% | 0.78 89.44% | 0.77 1.49% | |
market cap | 396.20M - | 734.25M 85.32% | 787.03M 7.19% | 262.09M 66.70% | 437.00M 66.74% | 398.77M 8.75% | 273.27M 31.47% | 353.81M 29.47% | 262.02M 25.94% | 210.79M 19.55% | |
net current asset value | 63.25M - | 18.24M 71.17% | 34.67M 90.11% | -31.55M 190.99% | 35.67M 213.06% | 53.66M 50.45% | 21.88M 59.22% | -21.80M 199.62% | -13.88M 36.33% | 15.72M 213.25% | |
net debt to ebitda | 3.37 - | 18.43 447.56% | -14.65 179.48% | 2.62 117.90% | -11.95 555.74% | 20.73 273.44% | -2.73 113.17% | 1.61 159.08% | -1.24 177.08% | 1.77 242.61% | |
net income per share | -0.39 - | -0.13 67.94% | 0.23 286.85% | -0.89 479.39% | 0.05 105.83% | -0.31 704.04% | -0.90 186.04% | -0.74 17.05% | -1.24 67.38% | -0.09 92.44% | |
operating cash flow per share | -0.36 - | 3.89 1,176.79% | -0.68 117.57% | -0.88 29.26% | -0.55 37.41% | 0.52 194.31% | -0.66 225.74% | -0.73 11.97% | -0.24 67.27% | -0.40 68.26% | |
payables turnover | 1.77 - | 1.62 - | 0.10 93.63% | ||||||||
receivables turnover | 0.11 - | 1.80 1,603.71% | 2.20 22.10% | 2.16 1.57% | 0.54 74.81% | 5.25 863.37% | 2.62 50.09% | 0.66 74.90% | 1.29 96.87% | 0.93 27.83% | |
research and ddevelopement to revenue | 1.67 - | 0.87 48.16% | 2.05 137.13% | 0.87 57.60% | 0.02 97.34% | 1.03 4,356.97% | 3.88 276.29% | 1.04 73.18% | 1.08 3.71% | ||
return on tangible assets | -0.23 - | -0.02 90.17% | 0.05 304.90% | -0.23 599.50% | 0.01 103.59% | -0.07 928.32% | -0.27 293.36% | -0.26 2.25% | -0.48 81.39% | -0.04 91.43% | |
revenue per share | 0.02 - | 0.34 1,754.12% | 1.04 210.91% | 0.60 42.41% | 1.36 126.40% | 1.03 24.16% | 0.72 30.16% | 0.15 78.85% | 0.62 309.33% | 0.65 3.50% | |
roe | -0.26 - | -0.09 64.66% | 0.15 257.64% | -0.56 483.74% | 0.02 103.24% | -0.10 628.92% | -0.45 370.38% | -0.55 21.35% | -1.83 232.50% | -0.15 92.03% | |
roic | -0.24 - | -0.14 42.42% | 0.08 155.04% | -0.42 648.06% | 0.03 107.82% | -0.11 443.68% | -0.08 25.76% | -0.40 374.82% | -0.20 49.74% | -0.11 47.19% | |
sales general and administrative to revenue | 13.79 - | 0.31 97.74% | 0.16 49.36% | 0.48 203.45% | 0.23 52.67% | 0.59 160.07% | 0.55 6.90% | 1.32 140.14% | 0.29 77.92% | ||
shareholders equity per share | 1.49 - | 1.35 9.30% | 1.60 18.53% | 1.58 1.13% | 2.85 79.92% | 3.25 14.20% | 1.98 39.19% | 1.35 31.64% | 0.68 49.66% | 0.65 5.12% | |
stock based compensation to revenue | 0.42 - | 0.06 86.42% | 0.02 67.49% | 0.30 1,540.77% | 0.03 88.75% | 0.06 63.71% | 0.04 21.49% | 0.22 396.15% | 0.09 60.38% | ||
tangible asset value | 69.26M - | 62.34M 10.00% | 77.09M 23.68% | 39.76M 48.42% | 82.71M 108.00% | 120.45M 45.63% | 109.69M 8.94% | 63.25M 42.34% | 52.59M 16.84% | 51.48M 2.11% | |
tangible book value per share | 1.38 - | 1.17 15.48% | 1.43 22.60% | 0.73 48.88% | 1.41 92.35% | 1.80 27.93% | 1.39 22.81% | 0.80 42.78% | 0.66 16.94% | 0.65 2.32% | |
working capital | 68.54M - | 191.96M 180.08% | 153.64M 19.97% | 63.61M 58.60% | 122.91M 93.21% | 115.78M 5.80% | 126.64M 9.38% | 58.37M 53.91% | 98.49M 68.74% | 108.38M 10.03% |
All numbers in USD (except ratios and percentages)